Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02836990 · ClinicalTrials.gov registry record · NA
Prevena™ vs Dermabond in Groin Wound Infections in Vascular Surgery
A NA study, sponsored by State University of New York at Buffalo.
- Completed
- Registry status
- NA
- Development phase
- 105
- Enrollment target
NCT02836990 is a NA study that has completed, run by State University of New York at Buffalo. The registered enrollment target is 105 participants.
The verdict
NCT02836990, a NA study, has completed, sponsored by State University of New York at Buffalo.
- COMPLETED
- Registry status
- NA
- Development phase
- 105 participants
- Enrollment target
Study Summary
This study evaluates the clinical efficacy and cost effectiveness of Prevena Incision Management System versus Dermabond in preventing groin wound infections in patients who undergo vascular surgery requiring a groin wound. Half of the patients will receive Dermabond and the other half will receive the Prevena Incision Management System for their groin wounds.
Interventions
- DEVICE Prevena Incision Management System
- DEVICE Dermabond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2016-07 |
| Est. Completion | 2019-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02836990
The ClinicalTrials.gov registry entry for NCT02836990 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Prevena Incision Management System is the first listed.
NCT02836990 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02836990 about?
NCT02836990 is a clinical study titled "Prevena™ vs Dermabond in Groin Wound Infections in Vascular Surgery". This study evaluates the clinical efficacy and cost effectiveness of Prevena Incision Management System versus Dermabond in preventing groin wound infections in patients who undergo vascular surgery requiring a groin wound. Half of the patients will receive Dermabond and the other half will receive ...
What is the current status of trial NCT02836990?
This trial is currently completed. It is a NA study. The enrollment target is 105 participants. The study started on 2016-07. Estimated completion is 2019-09.
What interventions are being tested in trial NCT02836990?
The interventions under investigation include: Prevena Incision Management System (DEVICE), Dermabond (DEVICE).
Who is sponsoring clinical trial NCT02836990?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.